Improvement of depressive symptoms in patients with moderate-to-severe psoriasis treated with ustekinumab: an open label trial validated using beck depression inventory, Hamilton depression rating scale measures and 18fluorodeoxyglucose (FDG) positr
about
Improvement of depressive symptoms in patients with moderate-to-severe psoriasis treated with ustekinumab: an open label trial validated using beck depression inventory, Hamilton depression rating scale measures and 18fluorodeoxyglucose (FDG) positr
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Improvement of depressive symp ...... luorodeoxyglucose (FDG) positr
@en
Improvement of depressive symp ...... luorodeoxyglucose (FDG) positr
@nl
type
label
Improvement of depressive symp ...... luorodeoxyglucose (FDG) positr
@en
Improvement of depressive symp ...... luorodeoxyglucose (FDG) positr
@nl
prefLabel
Improvement of depressive symp ...... luorodeoxyglucose (FDG) positr
@en
Improvement of depressive symp ...... luorodeoxyglucose (FDG) positr
@nl
P2093
P50
P1476
Improvement of depressive symp ...... luorodeoxyglucose (FDG) positr
@en
P2093
Byung-Soo Kim
Gun-Wook Kim
Hoon-Soo Kim
Hyun-Chang Ko
Junhee Han
Kyoungjune Pak
Min-Young Park
Moon-Bum Kim
Seong-Jang Kim
P304
P356
10.1080/09546634.2018.1466021
P50
P577
2018-04-16T00:00:00Z